Clinical Trials Logo

Comparative Study clinical trials

View clinical trials related to Comparative Study.

Filter by:
  • None
  • Page 1

NCT ID: NCT06384326 Completed - Acceptability Clinical Trials

Parental Perceptions and Acceptance of Silver Diamine Fluoride in Spain and Italy

SDF
Start date: September 1, 2020
Phase:
Study type: Observational [Patient Registry]

Assessing parental aesthetic acceptability of Silver Diamine Fluoride (SDF) staining is crucial for its potential implementation in paediatric dentistry. This study represents the third part of a wider project initially focused on evaluating SDF aesthetic acceptability in Italy, then comparing it between Spanish and Italian parents

NCT ID: NCT06229561 Completed - Comparative Study Clinical Trials

Soft Tissue Graft Versus Acellular Dermal Matrix in Preservation of Buccal Plate of Bone

Start date: January 18, 2020
Phase: Phase 1/Phase 2
Study type: Interventional

Comparative study between 2 groups to assess the feasibility of using Acellular dermal matrix vs Soft tissue Graft after immediate implant placement

NCT ID: NCT06199544 Recruiting - Comparative Study Clinical Trials

Effect of Unani Medicine for the Management of Anomalies Associated With Polycystic Ovarian Syndrome

Start date: October 1, 2022
Phase: Phase 1
Study type: Interventional

Currently available medications for PCOS are symptom(s) oriented but have limitations because of its complex pathophysiology. The most preferred drug against PCOS is metformin which act as an insulin sensitizer to improve insulin-glucose metabolism and anovulatory cycles in PCOS. However, its use is associated with various side effects such as bloating, diarrhea and nausea. Thus, it is imperative to explore various other alternatives to combat this gynecological problem.

NCT ID: NCT05779462 Not yet recruiting - Endometriosis Clinical Trials

ENDOMETRIOSIS - MRI

ENDO-MRI
Start date: July 2023
Phase:
Study type: Observational

Endometriosis is a frequent pathology with an estimated prevalence of 10% of women of childbearing age. There is no exact correspondence between the symptoms described by the patients and the severity of the lesions, which makes clinical diagnosis difficult. It therefore seems important to improve the complementary examinations available to make the diagnosis more precise and to better study the effectiveness of the treatments implemented. The clinical examination and per-surgical findings of patients with deep pelvic endometriosis show a clear decrease in the mobility of the pelvic organs in relation to each other, but few studies have looked at this mobility, which could however have an implication in explaining the pathophysiology of the disease and the symptomatology of the patients, as well as in the detection of lesions preoperatively. The persistence of hypo-mobility could also help to understand treatment failures.

NCT ID: NCT02444468 Recruiting - Ankle Fractures Clinical Trials

Preoperative Treatment of Malleolar Fractures

Start date: March 2015
Phase: N/A
Study type: Interventional

This study investigates, in a randomized setting, the use of intermittent in-cast pneumatic foot-compression (IPC) in the preoperative treatment of malleolar fractures. This is to investigate whether the IPC has any effect on preventing swelling of the ankle, and thereby preventing delay of surgery due to swelling. The investigators will include patients with malleolar fractures that require surgery in two groups, IPC and bandage or bandage only, and measure the time from diagnosis-to-surgery.

NCT ID: NCT01183247 Completed - Clinical trials for Immunosuppressive Agents

An Open, Single Centre, Randomised, Parallel Group Study to Investigate Three Different Immunosuppressive Regimens

SterFreePlus
Start date: July 2008
Phase: Phase 4
Study type: Interventional

An open, single center, randomised study to investigate three different immunosuppressive regimens for de novo renal transplant recipients: 1. st sirolimus / EC-MPS / tacrolimus regimen - After 3 months a protocol biopsy is performed. If no rejection is detected the calcineurin inhibitor (tacrolimus) is withdrawn. 2. nd everolimus / EC-MPS / tacrolimus regimen - After 3 months a protocol biopsy is performed. If no rejection is detected the calcineurin inhibitor (tacrolimus) is withdrawn. 3. rd tacrolimus / EC-MPS / prednisone regimen - After 3 months a protocol biopsy is performed. If no rejection is detected prednisone is withdrawn.